abstract |
Described herein are LPA1 receptor antagonists, pharmaceutical compositions comprising at least one LPA1 receptor anatgonist, and methods of treating or preventing dermal diseases or conditions. Pharmaceutical compositions are suitable for systemic admistration or for topical administration. |